Underscoring the complexity of the regulation of Mtss1, the levels of its mRNA were reduced upon expression of bcr-abl in murine CML models, but only partially restored by tyrosine kinase inhibitor treatment [26]. The gene discussed is MTSS1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.